ATENATIV 50UI / ml powder + solvent infusion solution medication leaflet

B01AB02 human antithrombin III • Blood and blood forming organs | Antithrombotic agents | Heparin group

Antithrombin III human is a concentrated form of antithrombin derived from human plasma, used in the treatment and prevention of thrombotic complications in patients with congenital or acquired antithrombin deficiency. This natural protein inhibits enzymes in the coagulation cascade, including thrombin and factors Xa and IXa, preventing excessive blood clot formation.

Human antithrombin is administered intravenously, usually in emergency situations such as deep vein thrombosis, pulmonary embolism, or during surgical procedures in patients at high risk of thrombosis.

Side effects are rare but may include allergic reactions, fever, or thrombocytopenia. Administration must be performed under strict medical supervision, with careful monitoring of coagulation parameters.

Antithrombin III human is a vital medication for managing coagulation disorders, helping to prevent severe complications and maintain hemostatic balance.

General data about ATENATIV 50UI / ml

Substance: human antithrombin III

Date of last drug list: 01-06-2025

Commercial code: W66671001

Concentration: 50UI / ml

Pharmaceutical form: powder + solvent infusion solution

Quantity: 1

Product type: original

Price: 949.58 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: OCTAPHARMA AB - SUEDIA

Holder: OCTAPHARMA (IP) SPRL - BELGIA

Number: 15636/2024/01

Shelf life: 3 years

Concentrations available for human antithrombin III

500UI, 50UI/ml